생리활성 펩타이드 및 뉴트라슈티컬 성분 시장 예측(-2032년) : 유래별, 성분 유형별, 형태별, 작용기전별, 유통 채널별, 용도별, 지역별 세계 분석

According to Stratistics MRC, the Global Bioactive Peptides & Nutraceutical Ingredients Market is accounted for $59.12 billion in 2025 and is expected to reach $98.09 billion by 2032 growing at a CAGR of 7.5% during the forecast period. Bioactive Peptides & Nutraceutical Ingredients Foods refer to advanced food products enriched with health-promoting compounds that go beyond meeting standard dietary needs. Bioactive peptides, obtained from protein breakdown, play roles in improving immune response, heart health, digestion, and metabolism. Nutraceutical ingredients such as probiotics, antioxidants, botanical extracts, vitamins, and minerals contribute to enhanced wellness and reduced health risks. These foods integrate nutrition with therapeutic benefits, supporting long-term health, functional performance, and preventive healthcare through everyday dietary consumption.

Market Dynamics:

Driver:

Aging global population

Older consumers are increasingly seeking functional ingredients that support healthy aging, immunity, muscle maintenance, and cognitive function. Bioactive peptides are widely recognized for their benefits in cardiovascular health, bone strength, and metabolic regulation. As life expectancy increases, preventive nutrition is becoming a priority over reactive healthcare solutions. Nutraceutical formulations enriched with peptides are being incorporated into daily diets through supplements and fortified foods. Healthcare professionals are also recommending peptide-based nutrition to manage age-related chronic conditions. This demographic shift is steadily expanding the consumer base across both developed and emerging economies.

Restraint:

Complexity of bioavailability

Peptides are highly sensitive to digestive enzymes, which can reduce their efficacy when consumed orally. Ensuring stability during processing, storage, and digestion requires advanced encapsulation and delivery technologies. Variability in absorption rates among individuals further complicates product standardization. Manufacturers must invest heavily in clinical validation to demonstrate efficacy claims. Regulatory scrutiny around functional benefits also increases development timelines and costs. These technical and scientific complexities can restrain faster commercialization of peptide-based nutraceuticals.

Opportunity:

Plant-based & vegan shift

Consumers are increasingly demanding alternatives to animal-derived peptides due to ethical, environmental, and health concerns. Advances in plant protein hydrolysis are enabling the development of effective peptide ingredients from sources such as soy, peas, rice, and algae. Vegan nutraceuticals are gaining traction in sports nutrition, weight management, and wellness supplements. Clean-label trends are further supporting the adoption of naturally derived bioactive compounds. Food and supplement brands are reformulating products to cater to flexitarian and vegan consumers. This transition is expanding application potential across global nutraceutical markets.

Threat:

Competition from synthetic alternatives

Synthetic alternatives often offer lower production costs and higher formulation stability. These ingredients can be engineered for targeted functionality, making them attractive to mass-market manufacturers. Pharmaceutical-grade synthetic compounds also benefit from well-established regulatory pathways. In comparison, natural peptides require extensive research to validate health claims. Price-sensitive markets may prefer synthetic substitutes over bio-based ingredients. This competitive pressure can impact market penetration for naturally sourced bioactive peptides.

Covid-19 Impact:

The COVID-19 pandemic significantly influenced demand patterns in the bioactive peptides and nutraceutical ingredients market. Heightened awareness of immune health led to increased consumption of functional foods and dietary supplements. Supply chain disruptions initially affected raw material sourcing and manufacturing operations. However, digital sales channels and e-commerce platforms helped offset traditional retail slowdowns. Research activities related to immunity-enhancing peptides accelerated during the pandemic period. Regulatory agencies also showed flexibility in fast-tracking certain nutraceutical approvals. Post-pandemic, consumers continue to prioritize preventive nutrition, sustaining long-term market growth.

The bioactive peptides segment is expected to be the largest during the forecast period

The bioactive peptides segment is expected to account for the largest market share during the forecast period, driven by the wide range of physiological benefits associated with peptide-based ingredients. Bioactive peptides are extensively used in supplements targeting heart health, muscle recovery, digestion, and immunity. Their proven efficacy in clinical and functional nutrition applications supports strong consumer trust. Ongoing advancements in enzymatic hydrolysis and extraction technologies are improving peptide yield and performance. Food and beverage manufacturers are increasingly incorporating peptides into functional formulations.

The cosmetic & personal care segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cosmetic & personal care segment is predicted to witness the highest growth rate. Bioactive peptides are gaining popularity for their anti-aging, skin repair, and collagen-boosting properties. Increasing consumer demand for science-backed skincare solutions is accelerating peptide adoption. Natural and bio-derived cosmetic ingredients are preferred over synthetic chemicals. Peptides are widely used in serums, creams, and dermal formulations for targeted skin benefits. Growth in premium and cosmeceutical product categories is further driving demand.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the region benefits from high consumer awareness regarding functional nutrition and preventive healthcare. Strong presence of nutraceutical manufacturers and research institutions supports product innovation. Regulatory frameworks allow structured commercialization of evidence-backed nutraceuticals. High disposable incomes enable greater spending on premium supplements and functional foods. The sports nutrition and healthy aging segments are particularly strong in this region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to rapid urbanization and changing dietary habits. Rising middle-class populations are increasingly investing in health and wellness solutions. Traditional medicine systems are also integrating bioactive peptides into modern nutraceutical formats. Countries such as China, Japan, India, and South Korea are emerging as key growth markets. Expanding manufacturing capabilities and local sourcing of raw materials support cost efficiency.

Key players in the market

Some of the key players in Bioactive Peptides & Nutraceutical Ingredients Market include Arla Foods Ingredients Group P/S, Peptan, Kerry Group plc, Roquette Freres, Glanbia plc, Danone S.A., Royal DSM N.V., Nestle S.A., BASF SE, Hilmar Ingredients, Cargill, Incorporated, FrieslandCampina, Ingredion Incorporated, Ajinomoto Co., Inc., and Archer Daniels Midland Company (ADM).

Key Developments:

In December 2025, BASF, San Fang Chemical Industrial Co., Ltd. and Nichetech Advanced Materials Co., Ltd. have signed a Memorandum of Understanding (MoU) to jointly develop sustainable solutions for the footwear industry, with a focus on thermoplastic polyurethane (TPU) products and a shared ambition to achieve net-zero carbon emissions by 2050.

In October 2025, Mars and Cargill, announced they are spurring the development of more than 224MWac* of new renewable energy capacity through five virtual power purchase agreements (PPAs) in Poland. The PPAs were signed with GoldenPeaks Capital, one of Europe's fastest-growing independent producers of renewable energy.

Sources Covered:

• Plant-Derived Proteins & Peptides
• Animal-Derived Proteins & Peptides
• Marine-Derived Proteins & Peptides
• Fermentation-Derived Peptides
• Synthetic Peptides & Ingredients

Ingredient Types Covered:

• Bioactive Peptides
• Amino Acids & Protein Fractions
• Prebiotics & Probiotics
• Phytochemicals & Plant Extracts
• Omega-3 & Fatty Acid Derivatives
• Vitamins, Minerals & Specialty Nutrients

Forms Covered:

• Powder
• Liquid
• Capsules
• Other Foams

Mechanisms Covered:

• Antioxidant Peptides
• Antimicrobial Peptides
• Antihypertensive
• Immune-Regulating Peptides
• Anti-Inflammatory
• Weight Management & Metabolic Peptides

Distribution Channels Covered:

• Direct B2B
• Retail
• E-Commerce

Applications Covered:

• Nutraceuticals & Dietary Supplements
• Functional Food & Beverages
• Pharmaceuticals & Clinical Nutrition
• Cosmetic & Personal Care
• Animal Nutrition & Feed
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Source

• 5.1 Introduction
• 5.2 Plant Derived Proteins & Peptides
• 5.3 Animal Derived Proteins & Peptides
• 5.4 Marine Derived Proteins & Peptides
• 5.5 Fermentation Derived Peptides
• 5.6 Synthetic Peptides & Ingredients

6 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Ingredient Type

• 6.1 Introduction
• 6.2 Bioactive Peptides
  • 6.2.1 Collagen Peptides
  • 6.2.2 Milk & Casein Peptides
  • 6.2.3 Egg Peptides
  • 6.2.4 Soy & Plant Peptides
• 6.3 Amino Acids & Protein Fractions
• 6.4 Prebiotics & Probiotics
• 6.5 Phytochemicals & Plant Extracts
• 6.6 Omega 3 & Fatty Acid Derivatives
• 6.7 Vitamins, Minerals & Specialty Nutrients

7 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Form

• 7.1 Introduction
• 7.2 Powder
• 7.3 Liquid
• 7.4 Capsules
• 7.5 Other Foams

8 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Mechanism

• 8.1 Introduction
• 8.2 Antioxidant Peptides
• 8.3 Antimicrobial Peptides
• 8.4 Antihypertensive
• 8.5 Immune Regulating Peptides
• 8.6 Anti Inflammatory
• 8.7 Weight Management & Metabolic Peptides

9 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Distribution Channel

• 9.1 Introduction
• 9.2 Direct B2B
• 9.3 Retail
  • 9.3.1 Supermarkets & Hypermarkets
  • 9.3.2 Specialty Stores
• 9.4 E Commerce

10 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Application

• 10.1 Introduction
• 10.2 Nutraceuticals & Dietary Supplements
• 10.3 Functional Food & Beverages
• 10.4 Pharmaceuticals & Clinical Nutrition
• 10.5 Cosmetic & Personal Care
• 10.6 Animal Nutrition & Feed
• 10.7 Other Applications

11 Global Bioactive Peptides & Nutraceutical Ingredients Market, By Geography

• 11.1 Introduction
• 11.2 North America
  • 11.2.1 US
  • 11.2.2 Canada
  • 11.2.3 Mexico
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 Italy
  • 11.3.4 France
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 Japan
  • 11.4.2 China
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 New Zealand
  • 11.4.6 South Korea
  • 11.4.7 Rest of Asia Pacific
• 11.5 South America
  • 11.5.1 Argentina
  • 11.5.2 Brazil
  • 11.5.3 Chile
  • 11.5.4 Rest of South America
• 11.6 Middle East & Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 Qatar
  • 11.6.4 South Africa
  • 11.6.5 Rest of Middle East & Africa

12 Key Developments

• 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 12.2 Acquisitions & Mergers
• 12.3 New Product Launch
• 12.4 Expansions
• 12.5 Other Key Strategies

13 Company Profiling

• 13.1 Arla Foods Ingredients Group P/S
• 13.2 Peptan
• 13.3 Kerry Group plc
• 13.4 Roquette Freres
• 13.5 Glanbia plc
• 13.6 Danone S.A.
• 13.7 Royal DSM N.V.
• 13.8 Nestle S.A.
• 13.9 BASF SE
• 13.10 Hilmar Ingredients
• 13.11 Cargill, Incorporated
• 13.12 FrieslandCampina
• 13.13 Ingredion Incorporated
• 13.14 Ajinomoto Co., Inc.
• 13.15 Archer Daniels Midland Company (ADM)